Avalo Therapeutics (AVTX) Shares Outstanding (Diluted) (2015 - 2026)
Avalo Therapeutics (AVTX) Shares Outstanding (Diluted) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 10.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 680.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | 20.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.11 Mn |
| Dec 31, 2025 | 13.40 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 10.83 Mn |
| Mar 31, 2025 | 10.51 Mn |
| Dec 31, 2024 | 7.50 Mn |
| Sep 30, 2024 | 10.78 Mn |
| Jun 30, 2024 | 7.65 Mn |
| Mar 31, 2024 | 859,381.00 |
| Dec 31, 2023 | 277,727.00 |
| Sep 30, 2023 | 195,006.00 |
| Jun 30, 2023 | 58,263.00 |
| Mar 31, 2023 | 48,884.00 |
| Dec 31, 2022 | 39,233.00 |
| Sep 30, 2022 | 39,255.00 |
| Jun 30, 2022 | 39,202.00 |
| Mar 31, 2022 | 39,196.00 |
| Dec 31, 2021 | 12,083.00 |
| Sep 30, 2021 | 12,083.00 |
| Jun 30, 2021 | 12,083.00 |